ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is an implant injected into the eye (vitreous) and used for the treatment of diabetic macular edema (DME) in patients who have been treated with corticosteroids before and did not have a significant increase in eye pressure.
ILUVIEN may be an option even if you have been treated for DME before. You may not be a candidate for ILUVIEN if you have been treated for increased pressure within the eye or glaucoma within the past.
ILUVIEN may be an option even if you have been treated for DME before. You may not be a candidate for ILUVIEN if you have been treated for increased pressure within the eye or glaucoma within the past.
Location: Denmark
Phone: +1 678-990-5740
Investors 1
| Date | Name | Website |
| - | SWK Holdin... | swkhold.co... |
Mentions in press and media 1
| Date | Title | Description |
| 13.10.2021 | Alimera Sciences : Recent 24-Month Real-World PALADIN Data Demonstrate the Ability of ILUVIEN® to Significantly Reduce Treatment Burden in Patients with Diabetic Macular Edema | PALADIN Study Data Presented at the American Society of Retina Specialists Shows That Post-ILUVIEN, the Percentage of Eyes Receiving One Yearly Treatment or Less Increased 3.2-Fold Compared to Pre-ILUVIEN ATLANTA, Oct. 13, 2021 (GLOBE NEWSW... |